News

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...
Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.
The World Health Organisation (WHO) on Friday (11th of July) announced that Burundi had effectively eliminated trachoma as a ...
It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...
KeraLink International, a nonprofit organization dedicated to eradicating corneal blindness globally, has an ambitious goal: ...
Cornea tattooing increases psychosocial functioning by treating depression and anxiety in patients with corneal leukoma.
Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...
Dry eye is very common, especially post corneal refractive surgery, and should be treated preoperatively with attention paid ...
Depending on what’s causing your dry eye, there are a number of treatments that can help with your symptoms. Learn more about your options.
Longer axial lengths, preoperative glaucoma drop use appear to raise the risk for hypotony following vitrectomy for epiretinal membrane.
Three surgical techniques for aphakia correction each provide good refractive, visual acuity, and safety outcomes.